openPR Logo
Press release

US Melanoma Market is expected to reach US$3.2 billion by 2023

05-25-2017 02:04 PM CET | Health & Medicine

Press release from: Market Research Future

US Melanoma Market is expected to reach US$3.2 billion by 2023

Market Highlights:

The US melanoma market has been evaluated as fast growing market and it is expected that the market will continue to grow similarly in the near future. Melanoma is a type of cancer that develops from pigment containing cells known as melanocytes. It is the most dangerous type of skin cancer. The tumor can be either malignant or benign. Types of melanoma are superficial spreading melanoma, nodular melanoma, lentigo maglina melanoma, acral lentigious melanoma, and others. About 98% of melanoma is localized in the US.

US melanoma market was about US$ 2.4 billion in 2015 and is expected to reach US$ 3.2 billion by 2023 at a CAGR of 8.3%.

Test the market data and market information presented through more than 25 market data tables and figures spread over 51 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “US Melanoma Market Research Report – Global Forecast to 2023.”

US Melanoma Market Players:

• Amgen, Inc.,
• Bristol-Myers Squibb,
• Eisai Co. Ltd.,
• F. Hoffmann-La Roche Ltd.,
• Genentech Inc.
• Janssen Biotech, Inc.,
• Novartis International AG.
• Pfizer,
• Vical
• Ziopharm.

Regional Analysis:
Melanoma market in the US is divided into sates comprising of Georgia, New Jersey, North Carolina, New York, Florida, Illinois, Ohio, Pennsylvania, Texas, Washington, California, Virginia and Rest of US. California accounts for the largest market for melanoma in US followed by Florida and Ohio.

In the US, California and Florida are key regions for Melanoma market. Large number of melanoma cases is found in this region. New York is third largest market after Florida. In the US the incidence of melanoma is found to be increasing due to indoor tanning. Tanning devices are used in spas, salons, hotels and sporting facilities. Tanning devices emit UV radiations thus increasing the risk of cancer. Technological advancement in the field of treatment and diagnosis of melanoma in the US also drives this market. Government initiates to tackle these diseases are also important drivers for this market.

Request a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/2950

US Melanoma Market, By Type, 2016
US melanoma market has been segmented on the basis of type (superficial, nodular, lentigo maglina, acral, polypoid, desmoplastic), by gender (male and female), by treatment (immunotherapy, biologic therapy, radiation therapy, chemotherapy, surgery and others), by diagnosis (ABCDE, ugly duckling, biopsy, and others) and by end users (hospitals, pharmaceutical companies, research centers, clinics, laboratories).

Commenting on the report, an analyst from Market Research Future (MRFR)’s team said “The market for melanoma in US is a developing market and is expected to have remarkable growth and demand in the coming future. This large growth of this market is majorly attributed to increased exposure to ultra violet light and use of tanning devices. Superficial spreading melanoma is a type of melanoma which affects large number of people in the US.”

Access Report Details @ https://www.marketresearchfuture.com/reports/us-melanoma-market-2950

Brief TOC

1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Drivers
Continued…..

Browse Related Report

Global Clinical Laboratory Test Market Information, by test type (Complete Blood Count, HGB/HCT Tests, Basic Metabolic Panel, BUN Creatinine Tests, Electrolyte Testing, HbA1c Tests, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, Lipid Panel), by laboratory type (Primary Care clinics, Central laboratories) - Forecast to 2022

https://www.marketresearchfuture.com/reports/clinical-laboratory-test-market-1649

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US Melanoma Market is expected to reach US$3.2 billion by 2023 here

News-ID: 551123 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Melanoma

Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
The Metastatic Melanoma Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Metastatic Melanoma Therapeutics Market Size During the Forecast Period? The market size for therapeutics in metastatic melanoma has swiftly increased in the past few years. It is projected to augment
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
What combination of drivers is leading to accelerated growth in the metastatic melanoma therapeutics market? The growth of the metastatic melanoma therapeutics market is anticipated to be fueled by the increasing prevalence of melanoma cases. Melanoma, a type of skin cancer, originates in the cells, known as melanocytes, that determine the skin's pigment. Melanomas can develop on any part of the skin. Metastatic melanoma therapeutics comprise various treatments designed to interrupt
Key Influencer in the Melanoma Therapeutics Market 2025: Surge In Melanoma Incid …
How Are the key drivers contributing to the expansion of the melanoma therapeutics market? The rise in melanoma cases is predicted to fuel the expansion of the melanoma therapeutics market. Melanoma, a type of skin cancer, begins in the melanocytes. The therapies and medications used to treat melanoma patients and mitigate the effects of cancer are known as melanoma therapeutics. An increase in melanoma cases, therefore, leads to a surge in
Skin Cancer Market By Cancer Type (Melanoma, Non-melanoma)
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00018117/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: • Pfizer Inc. • Bristol-Myers Squibb Company • Abbott Laboratories • Amgen, Inc. • Merck & Co., Inc. • Novartis AG • F. Hoffmann-La Roche Ltd • Sanofi S.A. • Qiagen NV • Sun Pharmaceutical Industries Ltd
Melanoma Diagnostics Market - Shining Light on Melanoma: Transforming Lives with …
Newark, New Castle, USA - new report, titled Melanoma Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Melanoma Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Melanoma Diagnostics market. The report offers an overview of the market, which
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic